Home / Fact sheets / Spain / Spain (Basque Country) / Breast qualitative data

Country fact sheet: Spain (Basque Country)


Reporting year for qualitative data: 2020
Source of qualitative data: Directly from Programme

Organization of screening

An individual/team/institution responsible to coordinate the programme: Yes
Dedicated budget for screening programme: Yes
Documented cancer screening policy: Yes
Nature of documentation of the policy: Notification
Year programme was initiated: 1995
Programme introduction was preceded by a pilot: Yes, pilot evaluated and report published
Screening tests provided free of charge: Yes
Diagnostic tests provided free of charge: Yes
Treatment services provided free of charge: Yes

Information system and data collection

System that collects data: Individual & Aggregated
   • Identification of eligible population: Individual
   • Screening participation: Individual & Aggregated
   • Screening test results: Individual & Aggregated
   • Further assessment: Individual & Aggregated
   • Final pathology diagnosis: Individual & Aggregated
   • Cancer staging: Individual & Aggregated
   • Treatment: Individual & Aggregated
The information system exists at national or sub-national level: Individual: Sub-national
Aggregated: Sub-national
The information system collects data outside the programme (opportunistic screening/private sector): No
Cancer screening data is linked with population-based cancer registry (PBCR): Yes

Screening protocol

A screening protocol or guideline: Yes
Year of published/updated protocol: 2020
Target age (min-max) and screening interval [months] for each test: Mammography/DBT (50-69 years / [24 months])
All mammograms read by two radiologists independently: -

Invitations for screening and further assessment

Initiatives to create population awareness by the Health Ministry/Health Authority: Mass media campaign
Dedicated website
Invitations to eligible population: Yes
Source of the eligible individuals identified: Population register
Electorall roll
Method of invitation: Letter
Screen positive individuals actively contacted for further assessment: Yes
Individuals with a precancer or cancer diagnosis actively contacted: Yes

Quality Assurance (QA) of screening activities

Documented standard operating procedure/policy for QA: Yes
An individual/team/institution responsible for QA: Yes
Accreditation of mammography units: Yes
Accreditation of pathology services: Yes
Documented performance indicators: Yes
Reference standards for performance indicators: Yes
Evaluation reports published in the last five years: Yes

Sub-national data is available for:
   • Basque Country (2020)

Performance indicators

Reporting year for quantitative data: 2016
Source of quantitative data: Report (EU Report 2017)
Age range and regional limitation if applicable: 50-69 years
Invitation coverage (%): 57.5
Participation rate (%): 74
Examination coverage (%):
Completeness of data related to screening test results (%): 100
Completeness of data related to further assessment results (%): 99.3
Further assessment rate (%): 4.5
Further assessment participation rate (%): 99.3
Detection rate of CIS (x 1000): 4.48
Detection rate of invasive cancer (x 1000): 0.6
Detection rate of CIS and invasive cancer (x 1000):
Positive Predictive Value of abnormal screening test to detect CIS (x 1000): 9.3
Positive Predictive Value of invasive cancer (x 1000):
Positive Predictive Value of CIS and invasive cancer (x 1000):
More quantitative data (2013)

Check also the following factsheets: Spain, Cervical, Colorectal